CARA Historical Earnings image   This CARA historical earnings page last updated 8/10/2022
CARA Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/8/20220.02B
Q1 20225/9/20220.00B
Q4 20213/1/20220.00B
Q3 202111/8/20210.02B
Q2 20218/9/2021NA
Q1 20215/10/20210.00B
Q4 20202/25/20210.11B
Q3 202011/9/20200.01B
Q2 20208/10/20200.01B
Q1 20205/11/20200.01B
Q4 20192/27/20200.00B
Q3 201911/5/20190.01B
Q2 20198/7/20190.01B
Q1 20195/7/20190.00B
Q4 20183/12/20195.53M
Q3 201811/6/20185.06M
Q2 20188/7/20182.87M
Q1 20185/9/2018NA
Q4 20173/15/2018NA
Q3 201711/2/2017NA
Q2 20178/3/2017NA
Q1 20175/4/2017911000
Q4 20163/9/2017NA
Q3 201611/3/2016NA
Q2 20168/4/201679000
Q1 20165/5/20167000
Q4 20153/10/2016NA
Q3 201511/9/20152.44M
Q2 20158/10/2015874000
Q1 20155/12/2015489000
Q4 20143/26/2015914000
Q3 201411/10/20141.13M
Q2 20148/7/2014960000
Q1 20145/12/2014178000
Q4 20133/27/2014973000
CARA Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/8/2022-0.080
Q1 20225/9/2022-0.520
Q4 20213/1/2022-0.630
Q3 202111/8/2021-0.020
Q2 20218/9/2021-0.610
Q1 20215/10/2021-0.470
Q4 20202/25/20211.590
Q3 202011/9/2020-0.350
Q2 20208/10/2020-0.540
Q1 20205/11/2020-0.620
Q4 20192/27/2020-0.610
Q3 201911/5/2019-0.740
Q2 20198/7/2019-0.580
Q1 20195/7/2019-0.560
Q4 20183/12/2019-0.52
Q3 201811/6/2018-0.51
Q2 20188/7/2018-0.52
Q1 20185/9/2018-0.51
Q4 20173/15/2018-0.43
Q3 201711/2/2017-0.38
Q2 20178/3/2017-0.29
Q1 20175/4/2017-0.81
Q4 20163/9/2017-0.81
Q3 201611/3/2016-0.42
Q2 20168/4/2016-0.48
Q1 20165/5/2016-0.39
Q4 20153/10/2016-0.35
Q3 201511/9/2015-0.19
Q2 20158/10/2015-0.25
Q1 20155/12/2015-0.21
Q4 20143/26/2015-0.18
Q3 201411/10/2014-0.29
Q2 20148/7/2014-0.16
Q1 20145/12/2014-0.22
Q4 20133/27/2014-0.49
Quotes delayed 20 minutes

Email EnvelopeFree CARA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cara Therapeutics (CARA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CASI Historical Earnings
CATB Historical Earnings
CBAY Historical Earnings
CBIO Historical Earnings
CCCC Historical Earnings
CCEL Historical Earnings
CCRN Historical Earnings
CCXI Historical Earnings
CDAK Historical Earnings
CDMO Historical Earnings
What was the record high CARA historical earnings result?
In terms of earnings or revenue, what is the best CARA historical earnings result that Cara Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CARA historical earnings result was set in Q4 2020, when Cara Therapeutics posted results of 1.590/share. The most successful revenue quarter within our data set was Q4 2020 when Cara Therapeutics reported revenue of 0.11B.

What was the lowest Cara Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CARA has reported, and when?

✔️Accepted answer: Within our data set, the lowest CARA historical earnings result was set in Q1 2017, when Cara Therapeutics posted results of -0.81/share. The smallest revenue quarter within our data set was Q2 2021 when Cara Therapeutics reported revenue of NA.

On this page we presented the CARA historical earnings date information for Cara Therapeutics. Reviewing that CARA Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2020, when CARA posted gaap of 1.590/share. Meanwhile the lowest CARA historical earnings result was in Q1 2017, when CARA posted gaap of -0.81/share. Moving to Cara Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2020 when CARA reported 0.11B in revenue, while the smallest revenue quarter was Q2 2021 when CARA reported NA in revenue.

For self directed investors doing their due diligence on CARA or any other given stock, their research can benefit from looking into all of the Cara Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Cara Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CARA. Thanks for visiting, and the next time you need to research CARA historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of ACM, Devon Energy 13F Filers, Funds Holding PPLC.

 

CARA Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.